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Abstract: 
Background: In recent years, criticism of the percentage range approach for individualised exercise 
prescription has intensified and we were concerned that sub-optimal exercise dose (especially 
intensity) may be in part responsible for the variability in the effectiveness of cardiac rehabilitation 
(CR) programmes in the United Kingdom (UK). The aim was to investigate the fidelity of a structured 
Phase III CR programme, by monitoring and quantifying exercise training intensity.  
Design: Observational study.  
Methods: The programme comprised 16 sessions over 8 weeks, where patients undertook an interval, 
circuit training approach within national guidelines for exercise prescription (40-70% heart rate 
reserve [HRR]). All patients wore an Apple Watch (Series 0 or 2, Watch OS2.0.1, Apple Inc., California, 
USA). We compared the mean % heart rate reserve (%HRR) achieved during the cardiovascular 
training component (%HRR-CV) of a circuit-based programme, with the %HRR during the active 
recovery phases (%HRR-AR) in a randomly selected cohort of patients attending standard CR. We then 
compared the mean %HRR-CV achieved with the minimal exercise intensity threshold during 
supervised exercise (40% HRR) recommended by national governing bodies. 
Results: Thirty cardiac patients (83% male; mean age [SD] 67 [10] years; BMI 28.3 [4.6] kg∙m-2) were 
recruited. We captured 332 individual training sessions. The mean %HRR-CV and %HRR-AR were 37 
(10) %, and 31 (13) %, respectively. There was weak evidence to support the alternative hypothesis of 
a difference between the %HRR-CV and 40% HRR. There was very strong evidence to accept the 
alternative hypothesis that the mean %HRR-AR was lower than the mean %HRR-CV (median 
standardised effect size 1.1 (95%CI: 0.563 to 1.669) with a moderate to large effect.   
Conclusion: Mean exercise training intensity was below the lower limit of the minimal training 
intensity guidelines for a Phase III CR programme. These findings may be in part responsible for 
previous reports highlighting the significant variability in effectiveness of UK CR services and poor CRF 
improvements observed from several prior investigations.  
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Introduction  
Cardiovascular disease accounted for 15 million deaths worldwide in 2015.1 The cornerstone of 
secondary prevention strategies is comprehensive cardiac rehabilitation (CR), including optimal 
medical therapy and lifestyle interventions which have been endorsed within United Kingdom (UK),2,3 
European,4 and North American5 guidelines. The literature on supervised, structured exercise training 
as a key component of comprehensive CR has been less than convincing. The largest RCT of structured 
CR within the UK showed no benefits to all-cause mortality. In 2013, Sandercock et al6 quantified 
exercise training volumes and changes in cardiorespiratory fitness (CRF) in 950 cardiac patients 
undertaking Phase III CR across 4 centers in the UK. Patients completed 6 to 16 (median 8) supervised 
exercise sessions. CRF improvements showed an overall mean increase of only 0.52 METs; a third the 
mean estimate (1.55 METs) reported from the investigators earlier systematic review of the 
international CR literature.7 In 2016, Almodhy et al8 conducted a meta-analysis of UK CR studies in 
order to determine if programmes could promote meaningful changes in CRF. It was concluded that 
UK studies provided approximately one-third of the exercise "dose", and produced gains in CRF less 
than half the magnitude reported in the wider international studies.8 There are also challenges 
regarding the reporting of CR studies; Mitchell and colleagues,9 published a comprehensive systematic 
review and meta-analysis reporting a lack of consensus in the consistency of reporting of exercise 
interventions in CR studies. This highlights ongoing issues regarding lack of standardisation indicating 
the need for further high quality, robust CR trials.      
 
The FITT principle describes the four components of exercise prescription: Frequency, Intensity, Time 
(duration), and Type of exercise which combine to create the exercise “dose”. Of these, exercise 
intensity is arguably the most critical component for improving CRF, and is the least standardised in 
clinical practice.10 In the UK, CR programmes follow traditional approaches by prescribing exercise 
intensity based on a percentage range of heart rate reserve (%HRR; heart rate reserve being the 
differences between the maximal and resting heart rate, often with an adjustment if a patient is 
prescribed a medication which impacts chronotropic response, e.g. beta blockers). This method is 
recommended by a number of national associations including the American College of Sports 
Medicine,11 and in the UK, the Association of Chartered Physiotherapists in Cardiovascular 
Rehabilitation (ACPICR),12 and the British Association of Cardiovascular Prevention and Rehabilitation 
(BACPR).3  
 
Typically, structured Phase III CR is delivered in a community setting with the aim of achieving 20–60 
min of moderate intensity continuous or interval-based exercise, 3–5 times per week, alongside 
resistance-based training.12 In addition, most comprehensive CR programmes would include an 
educational component, dietary advice, and psychological support.13 Most often in the UK, patients 
undertaking a Phase III programme would initially participate in group-based circuit training, following 
an interval training approach. Typically, patients would alternate between cardiovascular (CV) training 
interspersed with a period of active recovery (AR). The initial work: rest ratio would be dependent 
upon initial risk stratification and knowledge of existing individual baseline fitness levels. The goal 
would be to increase the dose of exercise by increasing the CV component and removing AR stations 
based on individual progress, with the ultimate aim that the patient is able to undertake continuous 
moderate intensity exercise. Importantly, for improvements in CRF, the CV component prescribed 
should be at an exercise intensity sufficiently high enough to induce physiological adaptation. Training 
intensity is based on an initial prescribed training zone utilising heart rate (HR) responses and/or 
ratings of perceived exertion (RPE). UK guidelines recommend an exercise intensity between 40-70% 
heart rate reserve (HRR).3,12  For AR stations, exercise HR and RPE levels should drop below prescribed 
exercise intensity levels to allow patients a brief period of respite.12  
 
In recent years, criticism of the percentage range approach for individualised exercise prescription  
has intensified13,14 and we were concerned that sub-optimal exercise dose (especially intensity) may 
be, in part responsible for the variability in the effectiveness of UK CR programmes, which has been 
previously reported.15 To our knowledge, no previous study has investigated the fidelity of a 
structured Phase III CR programme by monitoring and quantifying the exercise intensity achieved 
during an overall 8-week programme. We aimed to compare the mean percentage heart rate reserve 
(%HRR) achieved during the cardiovascular training component (%HRR-CV) of the programme, with 
the %HRR during the AR phases (%HRR-AR). Moreover, we compared the mean %HRR-CV achieved 
with the minimal exercise intensity threshold (40% HRR) recommended by national governing 
bodies.3, 11 
 
Methods 
The study was approved by the North West National Health Service (NHS) Research Ethics Committee 
and institutional ethics committee prior to commencement of the study. All patients provided written 
informed consent before participating in the trial. The following patients were eligible to participate 
in the study: patients following myocardial infarction (MI), whose event had presented in the 
preceding 3-6 weeks, percutaneous coronary intervention (PCI) and coronary artery bypass graft 
(CABG) within the past 6 weeks, stable angina, valvular or aortic root repair, patients with devices such 
as pacemaker or implantable cardioverter defibrillator, and stable heart failure. We excluded patients 
who had orthopaedic or neurological limitations, unstable angina, New York Heart Association class 
IV heart failure, uncontrolled hypertension and diabetes, symptomatic hypotension, uncontrolled 
tachy-arrhythmias, and febrile illness. Patients were referred from their hospital doctor or general 
practitioner to a Phase III CR programme based in the North Eastern region of England in 2017 and 
2018.   
 
The standard, community-based Phase III CR programme included two sessions per week for eight 
weeks (16 sessions in total). Each training session consisted of a 45 minute structured exercise based 
activities (12 training hours over eight weeks). Each training session consisted of a 15-minute warm 
up at the beginning of each session followed by a circuit training programme consisting of 9 exercise 
stations (5 CV; 4 AR). The CV stations included: treadmill, static bike, step ups, sit-to-stand, and rowing. 
The AR stations included biceps curls, wall press, lateral arm raises, and leg curl exercises.  The session 
concluded with a 10-minute cool down period. All patients were advised not to consume caffeine at 
least three hours before the training sessions. In the UK, maximum heart rate is routinely estimated 
as there is little provision to conduct a maximal cardiopulmonary exercise test prior to routine CR. The 
following formula for calculating heart rate reserve (HRR) was used which is consistently advocated 
by national governing bodies (3, 11): 
 
Maximal heart rate was estimated using the following equation; HRR = 206 – (age x 0.7)16,17  
 
Resting heart rate was then deducted in order to calculate the HRR. A further deduction of 20-30 beats 
per min was made in patients who were prescribed beta-blockers, the decision to deduct 20 or 30 
beats is often based on a patient’s initial risk stratification.11 Heart rate training zones were calculated 
between 40-70% HRR in accordance with national guidelines.3, 11 In UK practice, patients often wear a 
heart rate monitor exercise classes which staff monitor periodically during CV exercise stations. 
 
In our investigation, each patient wore an Apple Watch (Series 0 or 2, Watch OS2.0.1, Apple Inc., 
California, USA) during each training session over the 8-week intervention. The Apple Watch uses 
photoplethysmysmography (PPT) to measure heart rate. PPT is a non-invasive technique which uses 
a sensor to measure changes in blood flow.18 We have recently shown that the Apple Watch heart 
rate sensor has very good validity during walking activities, and good validity during jogging activities. 
However, the validity of the device decreases as exercise intensities increase towards maximal levels.19 
During each training session, patients wore the watch on their left wrist with the exception of one 
patient who wore it on their right wrist due to an existing tattoo on their left side. Each Apple Watch 
was connected via Bluetooth to an iPhone 5s or iPhone 6 (Apple Inc., California, USA). We used the 
‘Workout’ app to measure heart rate nominally at five second intervals. A bespoke iPhone app was 
written by one of the co-authors (GA) to extract the raw heart rate and sampling time data from the 
‘Health’ database on the connected iPhone. The bespoke app was written using the Swift 2.1 language 
in XCode 7.2.1, utilising the methods supplied by the HealthKit framework (Apple Inc., California, USA).  
 
Statistical Analysis 
Mean and standard deviation (SD) are reported for normally distributed data. The mean %HRR for CV 
training and AR stations are reported separately. Data analysis was conducted in JASP (JASP Team, 
2018) using Bayesian statistical methods. Below we describe the statistical analysis for two 
comparisons: (1) comparing the mean %HRR during CV exercise time (%HRR-CV) against the lower 
bound of the recommended training intensity zone (40% HRR), and (2) comparing the mean %HRR-CV 
against the mean %HRR for AR stations (%HRR-AR). Patients were excluded from our analysis if they 
failed to complete less than 12 of 16 training sessions (<75% adherence rate).  
 
Comparing %HRR-CV and 40% HRR 
We compared %HRR-CV and 40% HRR both in the form of a hypothesis test using Bayes factors and as 
a parameter estimation for the posterior distribution of the standardised effect size. Our null 
hypothesis test compared the observed data against a null hypothesis of no difference between the 
mean %HRR-CV and 40% HRR-CV, which is the lower bound of the recommended training intensity 
zone.3,11 For this analysis we conducted a Bayesian one-sample t-test, using a two-sided alternative 
hypothesis because it is unknown if the mean %HRR-CV is above or below this lower bound. Given our 
uncertainty of the effect, we assigned a broad weakly informative prior using a zero-centred Cauchy 
distribution with scale r = 1/√2.   
 
Comparing %HRR-CV and %HRR-AR 
The same process was used to compare the mean %HRR-CV and mean %HRR-AR. We wanted to 
examine if the AR sections of the training sessions were in fact of lower intensity (and by what 
magnitude) compared to the CV section. For this analysis, we used a Bayesian paired-samples t-test 
with the same prior distributions. However, given that we were expecting the AR stations to be of 
lower intensity than CV sections, we used a one-sided alternative hypothesis.  
 
To describe the strength of evidence against the null hypothesis (or for the alternative hypothesis) we 
used the classification scheme of Jeffreys.20 A Bayes factor between one and three was considered as 
weak evidence; three and 10  moderate evidence, and above 10 is considered strong evidence. To 
describe the magnitude of the observed standardised effect size, we use the classification scheme of 
Cohen,21 with 0.2, 0.5 and 0.8 representing small, moderate, and large effects, respectively. 
Uncertainty in the parameter estimation is quantified using 95% credible intervals.  
 
Results 
Thirty cardiac patients [83% male; age (SD) 67.0 (10.0) years; body mass index (SD) 28.3 (4.6) kg∙m-2] 
were recruited to the Phase III CR programme. Of these, 87% were prescribed beta-blockers; 53% 
statins; 40% ACE-inhibitors; and 68% aspirin. These medications remained unchanged throughout the 
training intervention. Patients were randomly selected from a mixed cardiovascular disease aetiology: 
11 patients had received a coronary artery bypass graft, 7 percutaneous coronary intervention, and 2 
patients had undergone a mitral valve replacement. Amongst the non-surgical patients, 4 patients 
were post-myocardial infarction, 3 patients had diagnosed coronary heart disease, and 3 were 
diagnosed with chronic heart failure. Of the 30 patients who initially enrolled, 4 exhibited paroxysmal 
atrial fibrillation.  
 
Twenty patients (67% of the population) completed all 16 sessions (twice a week for eight weeks) of 
the Phase III CR programme; the remaining 10 patients dropped out at various stages of the 
programme due to a deterioration in their health, or were unable to attend due to personal reasons. 
Our analysis is based on 21 patients who had a programme adherence ≥75% (completed a minimum 
of 12 of 16 sessions). In total, we monitored 370 individual exercise training sessions, although data 
from 5 exercise sessions on selected patients were lost due to technical problems. Overall our analysis 
is based on 332 individual training sessions.  
 
CV training and AR – training intensity during the Phase III programme 
 
As displayed in Table 1, the mean (SD) %HRR-CV was 37 (10) %, with a 95% credible interval of 33 to 
42%. The Bayesian one-sample t-test (Figure 1) resulted in a Bayes10 factor of 0.474, indicating weak 
evidence for the alternative hypothesis that the observed data is different from 40% HRR. 
 
The mean (SD) %HRR-AR was 31 (13) %, which is approximately 6% lower than the mean %HRR-CV 
(Table 1). When comparing the mean %HRR-CV against the mean %HRR-AR (Figure 2), the Bayes10 
factor of 2076 indicates very strong evidence in favour of the alternative hypothesis. The median 
standardised effect size of 1.1 (95%CI: 0.563 to 1.669) suggests a moderate to large effect. Figure 3 
shows the overall mean and individual mean distributions of CV and AR components of an 8-week 
Phase III CR interval training programme. We noted that 67% of our patients had a mean HRR-CV% 
below 40% HRR, which is the lowest end of the exercise prescription guidelines advocated by national 
governing bodies.   
 
Discussion  
To the best of our knowledge, our study is the first UK-based study to monitor and quantify exercise 
training intensity during a structured, community-based Phase III CR programme. Recent reports have 
highlighted that CR programmes in the UK may be less effective than international programmes7, 9 and 
may not attain a sufficient exercise intensity to promote physiological adaptations and corresponding 
improvements in CRF. Our findings provide further support for these assertions. The mean exercise 
intensity during the CV training component of the Phase III programme was only 37 (10) % HRR (mean 
HR achieved <91 [12] bpm) which is below, (but not statistically), the minimum national guidelines for 
training intensity.3,11 Figure 3 highlights the large variability in mean training intensity received by 
patients on an individual basis, with 67% of our patients training at an intensity below the lowest 
threshold advocated by national governing bodies.3,11 
 
UK-based guidelines advocate a percentage range-based method for prescribing exercise intensity.3,11 
However, there are a number of limitations of this method; firstly, it fails to account for individual 
metabolic responses e.g. ventilatory and blood lactate responses to interval exercise,22 which is 
problematic given that exercise prescription is required to be personalised for patients with cardiac 
disease.11 Examples of this lack of personalisation have been demonstrated in previous studies,23-25 
which have shown considerable individual variation in blood lactate response to exercise when 
intensity is anchored to a relative percentage range. A heterogenous metabolic response to exercise 
training has been offered as a possible mechanism for the variability in effectiveness of exercise 
training programmes, thus resulting in positive responders and non-responders.26 Wolpern et al27 
conducted a randomised controlled trial to compare the effectiveness of a threshold-based model 
(ventilatory threshold) versus a relative percent model (%HRR) for improving cardiorespiratory fitness 
in 36 males and females. They found that the threshold-based model elicited significantly (P<0.05) 
greater improvements in VO2max compared to a %HRR model following 12 weeks of training. 
However, an interesting finding from this study was that the threshold-based model attenuated the 
individual variation in VO2max training responses when compared to the %HRR group. The authors 
reported considerable heterogeneity in terms of responders (41.7%), and non-responders (58.3 %) for 
eliciting changes in VO2max following training, which is consistent with other studies.22, 28 Wolpern et 
al26 showed that in the threshold-based training group, 100% of participants demonstrated a positive 
improvement in VO2max following training.  A mean improvement of 1.1 METs (full range: +0.65 to 
+1.63 METs) was reported among these young or middle aged previously sedentary groups. In 
contrast, only 41.7 % of participants experienced a significant improvement in VO2max in the %HRR 
group.   
 
In the UK, there are >300 registered CR programmes (Phase III and IV), which undoubtedly leads to 
issues in relation to consistency of service quality and delivery. In recent years, there have been some 
positive signs reported in relation to improved consistency of service provision. In 2015, the BACPR 
and National Association of Cardiac Rehabilitation (NACR) developed the National Certification 
programme for CR (NCP_CR) services, which sets out to improve delivery of CR, showcase good 
services, and seek to ensure the effectiveness of routine provision of CR programmes through 
achievement of a minimum level of service delivery across the UK.29, 30 
 
Doherty and colleagues15 recently conducted an audit to investigate how many UK CR programmes 
met minimal standards for delivery of the NCP_CR. The analysis used UK NACR data extracted and 
validated for the period 2013–2014 set against six NCP_CR measures recognised as important for the 
delivery of high-quality CR programmes. Data from 170 CR programmes revealed significant variability 
in terms of quality of service delivery; 30.6% were assessed as high performing, 45.9% as mid-level 
performing, 18.2% were classified as low performing, and 5.3% failed to meet any of the minimum 
criteria. These findings indicate that substantial variation, below the recommended minimum 
standards, exists throughout the UK. The six measures deemed important for high quality provision 
relate to the service being offered to all priority groups; ≥69% of patients with recorded assessments 
before starting a formal CR programme; ≥49% of patients with recorded assessment after completing 
a CR programme; median waiting time from referral to start of CR within 40 days (post-MI); median 
waiting time from referral to start of CR within 54 days (post-CABG); Median duration of CR 
programmes being 54 days for conventional delivery, or 42 days where the Heart Manual was used.15 
Currently, there are no criteria which relate to service effectiveness which, if incorporated, may assist 
with improving service outcomes at a national level.   
A limitation of current UK practice is that maximum heart rate is estimated, and not directly measured. 
Subsequently, adjustment for beta-blockade is added, and then a resting heart rate (RHR) value is 
included in the calculation. Each of these steps incur error of estimation, reducing the accuracy of the 
training heart rate range which is prescribed to the patient.31 Alternative and more valid equations for 
estimating heart rate maximum have been derived from specific cardiac cohorts which, crucially, have 
been adjusted for beta-blockade.32 It may be that a following a similar approach should be a 
recommendation for UK CR services. The timing of the RHR assessment is also important: 
cardiovascular physiology appears to follow a daily biorhythm; heart rate, blood pressure, and cardiac 
contractility all peak in the wake hours and reach a nadir during sleep.33 The suppressive eﬀect of 
propranolol, for example, on the rise in HR during exercise is signiﬁcantly greater if the drug is taken 
in the morning versus at night.34 Therefore, to ensure minimal variability in the daily RHR,  CR staff 
should be mindful that offering classes at regular times of the day will help minimise biorhythm 
disturbance. Secondly, checking patients timing and compliance of their beta-blocker medication will 
also assist with this goal. It is also possible that over time, cardiorespiratory may improve, potentially 
lowering the RHR. Furthermore, medication changes may also be responsible for an altered RHR. 
Therefore, CR staff should ensure that RHR is checked and recorded prior to the start of each training 
session in order to ensure a more precise estimation of the individualised HR training zone. Finally, 
the implementation of these processes are fundamental to effective practice, hence the requirement 
for ongoing professional development and education to ensure that CR service quality and standards 
are improved.  
 
A limitation of our study is that our detailed evaluation of training intensity from a Phase III 
community-based CR programme is based on findings from a single NHS centre and may not be 
representative of exercise training intensities or prescription methods undertaken in other centres. 
We have already acknowledged the high levels of inconsistent and variable quality of CR service 
provision in the UK. It is highly probable that many of the >300 UK CR programmes would be far more 
effective with patient outcomes being significantly greater than in the CR service we observed. 
Conversely, however, it is also possible that some other CR programmes may be inferior in terms of 
patient outcomes, therefore, the key is trying to improve the consistency of CR service provision and 
quality across the UK.         
 
Our study did not directly measure peak HR, rather it was estimated using a predictive equation, 
including the adjustment for beta-blockade. Therefore, we cannot say how accurately our training 
zone calculations were (compared to directly measured findings), however, we have systematically 
followed the process for estimating HR training zones as recommended by the BACPR and ACPICR in 
the UK. Consequently, we are confident that our study is pragmatic, and provides real-world 
application.     
 
We utilised two models of Apple watch in our study. It is possible that this technical issue may have 
introduced some degree of systematic error to our findings as we are not aware of the differences in 
technical specification between the models. 
 
In conclusion, within a heterogeneous cohort of patients with cardiovascular disease attending 
routine Phase III CR, mean exercise training intensity was below, but not significantly, the minimal 
exercise training intensity threshold (40% HRR) recommended within national guidelines in the UK. 
The generalisability of these findings requires further investigation. However, they may be in part 
responsible for previous reports highlighting the significant variability in effectiveness of UK CR 
services, and the poor improvements in CRF documented in patients undertaking CR in the UK 
compared to international standards.  
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List of Figures 
 
Figure 1. Prior and posterior effect size distributions, together with the effect size point estimate 
and associated 95% credible interval arising from a one-sample Bayesian t-test using a test value of 
40. The value of 40 represents the lower bound of the recommended training intensity zone. The 
resulting Bayes10 factor provides weak evidence for the alternative hypothesis. BF = Bayes factor.  
  
Figure 2. Prior and posterior effect size distributions, together with the effect size point estimate 
and associated 95% credible interval arising from a paired-sample Bayesian t-test examining the 
mean difference between %HRR-CV and %HRR-AR. The Bayes10 factor provides strong evidence for 
the alternative hypothesis that %HRR-AR is lower than %HRR-CV. The effect size of 1.1 suggests a 
large difference between the two means. BF = Bayes factor. 
 
Figure 3. The means (horizontal bar) and individual mean distributions of CV and AR components of 
an 8-week Phase III CR interval training programme. The grey zone represents the recommended 
training intensity following national guidelines (3,12). 
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Table 1.  Mean HR (beats per min) and %HRR for an 8-week Phase III circuit-based CR programme 
 
 
 Mean HR during CV       exercise     Mean HR during AR              Mean %HRR during CV exercise        Mean %HRR during AR 
Mean  90.6  87.0  37.1  31.5  
Median  88.0  84.0  37.0  34.0  
Std. Deviation  12.3  13.2  10.1  12.6  
Minimum  74.0  67.0  17.0  10.0  
Maximum  117.0  113.0  62.0  53.0  
 
HR=heart rate (bpm); CV=cardiovascular; AR=active recovery; %HRR=% heart rate recovery 
 
 
 
 
